TY  - GEN
AU  - Morris,Michael J
AU  - Pandit-Taskar,Neeta
AU  - Carrasquillo,Jorge
AU  - Divgi,Chaitanya R
AU  - Slovin,Susan
AU  - Kelly,William K
AU  - Rathkopf,Dana
AU  - Gignac,Gretchen A
AU  - Solit,David
AU  - Schwartz,Lawrence
AU  - Stephenson,Ryan D
AU  - Hong,Christina
AU  - Delacruz,Anthony
AU  - Curley,Tracy
AU  - Heller,Glenn
AU  - Jia,Xiaoyu
AU  - O'Donoghue,Joseph
AU  - Larson,Steven
AU  - Scher,Howard I
TI  - Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer
SN  - 1527-7755
PY  - 2009///0605
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Analgesics, Non-Narcotic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bone Neoplasms
KW  - Bone and Bones
KW  - drug effects
KW  - Docetaxel
KW  - Drug Resistance, Neoplasm
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Organometallic Compounds
KW  - Organophosphorus Compounds
KW  - Prostate-Specific Antigen
KW  - blood
KW  - Prostatic Neoplasms
KW  - Radiopharmaceuticals
KW  - Taxoids
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2008.20.4164
ER  -